Racial Disparities in Outpatient Referrals for Opioid Use Disorder Highlighted in Recent Study

A new study highlights racial disparities in outpatient referrals for opioid use disorder, revealing that Black patients are less likely to receive necessary follow-up care after overdose incidents. Efforts are needed to promote equity in emergency department treatment for OUD.
Recent research published in JAMA Network Open uncovers significant racial disparities in the outpatient treatment referral process for individuals who have experienced an opioid overdose. The study analyzed data from 10 hospitals, involving 1,683 patients, to investigate treatment patterns and referrals post-overdose. Findings reveal that only 17.8% of patients received a referral for ongoing outpatient care, while a higher proportion were provided with naloxone kits or prescriptions (42.4%), and a smaller segment received buprenorphine prescriptions (8.4%). Notably, Black patients were significantly less likely to be referred for outpatient treatment compared to white patients, with an adjusted odds ratio of 0.67, indicating a substantial gap in equitable care. Conversely, patients admitted to the hospital were more than three times as likely to receive a referral (adjusted odds ratio of 3.13). The study also identified geographic disparities across different hospital sites. The authors emphasized that these racial disparities in treatment referrals highlight a critical need for targeted interventions to ensure equitable treatment access and address systemic inequities in emergency department care for opioid use disorder (OUD). Addressing these gaps is essential to improving long-term outcomes for minority populations affected by the opioid crisis.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Promising Results for Ifinatamab Deruxtecan in Treating Extensive-Stage Small Cell Lung Cancer
Clinical trials highlight the promising efficacy and safety of ifinatamab deruxtecan in treating extensive-stage small cell lung cancer, offering new hope for patients with limited options.
Hypofractionated Radiotherapy Combined with Chemotherapy Shows Promise for Small Cell Lung Cancer Treatment
A new phase III trial shows that a three-week hypofractionated radiotherapy schedule combined with chemotherapy offers similar survival rates and fewer side effects compared to traditional treatment for LS-SCLC patients.
Understanding the Science of a 29-Minute Freedive Breath Hold Record
Discover how elite freedivers achieve extraordinary breath-holds, including a 29-minute world record, through advanced training, lung capacity, and mental discipline.
New Biomarkers in Gut Microbiome May Predict 'Invisible' Chronic Fatigue and Long COVID
Innovative research identifies hidden biomarkers in the gut microbiome that could revolutionize diagnosis and treatment of chronic fatigue syndrome and long COVID, offering hope for personalized care based on gut health insights.



